Reposted by James DeGregori
Nice to see this properly published: a framework for designing therapies targeting tumor-level dynamics rather than cell number. Led by Fred Thomas with contributions from @amdujon.bsky.social, @jdegregori.bsky.social, me, and many others apparently not on Bluesky. www.nature.com/articles/s41...
nature.com
When effective anticancer therapies are, in fact, destabilizing the tumor’s Group Phenotypic Composition - npj Precision Oncology
npj Precision Oncology - When effective anticancer therapies are, in fact, destabilizing the tumor’s Group Phenotypic Composition